Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Go back to Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights
(NASDAQ: ELDN) Delayed: 2.64 +0.02 (0.76%)
Previous Close $2.62    52 Week High
Open $2.74    52 Week Low
Day High $2.74    P/E N/A 
Day Low $2.59    EPS
Volume 158,507